RankAlpha logo
Back to Rankings

PHAT

PhathomB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
PHAT vs peer average
62/100
PHAT vs. peer average (B vs. C)
Grade spread
A 2 · B 1 · C 6 · D 2
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ARDX is the first available peer comparator.

Ardelyx — small-cap GI-focused developer with commercialization experience; useful commercial/market comparables.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerARDXArdelyx
PHAT
Phathom
ARDX
Ardelyx
Grade
B
C
Momentum
27
7
Value
41
41
Sentiment
96
94
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs ARDX

PHAT / ARDX
Grade Position
In line
PHAT vs. peer average (B vs. C)
62/100
Momentum
27
PHAT
Value
41
PHAT
Sentiment
96
PHAT

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PHAT
1
ARDX
ARDX
C
60/100
+1
2
IRWD
IRWD
A
100/100
-1
3
MNKD
MNKD
A
100/100
-1
4
AMPH
Amphastar Pharmaceuticals Inc Common
C
60/100
+1
5
SANA
Sana Biotechnology Inc Common
C
60/100
+1
ARDX is the first peer returned for this comparison set.